CD11b hyperactivation improves response to immunotherapy in pancreatic cancer. (September 2018) - Panni, R.; Herndon, J.; Knolhoff, B.; Hogg, G.; Gupta, V.; Fields, R.; Hawkins, W.; DeNardo, D.